Open AccessCurrent status of multidrug resistant tuberculosis in a tertiary care hospital of East Delhi
Author(s) -
Tanu Sagar,
N. P. Singh,
Bineeta Kashyap,
Ishmeet Kaur
Publication year - 2013
Publication title -
journal of postgraduate medicine/journal of postgraduate medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 52
eISSN - 0972-2823
pISSN - 0022-3859
DOI - 10.4103/0022-3859.118031
Subject(s) - medicine , tuberculosis , multiple drug resistance , tertiary care , family medicine , pediatrics , traditional medicine , drug resistance , pathology , microbiology and biotechnology , biology
Multidrug resistant tuberculosis (MDR-TB) is caused by infection due to Mycobacterium tuberculosis which is resistant to both isoniazid (INH) and rifampicin (RIF). It is caused by selection of resistant mutant strains due to inadequate treatment and poor compliance. MDR-TB is a major public health problem as the treatment is complicated, cure rates are well below those for drug susceptible tuberculosis and patient remains infectious for months despite receiving the best available therapy. The drug susceptibility pattern of M. tuberculosis is essential for proper control of MDR-TB in every health care setting, hence the study was initiated with the aim of studying the prevalence of MDR-TB in patients attending a tertiary care hospital in east Delhi.